Coronavirus -moderna

Moderna MRNA At Fresh Record Highs On Positive Results From The Coronavirus Vaccine

Biopharma Moderna MRNA is 15.56% higher at $76.68 making fresh record highs after the announcement of positive early-stage results from a Phase 1 study of its for mRNA-1273 coronavirus vaccine.

Continue reading with a free membership account. It takes seconds to create.


Register

Related Posts: